{
    "eid": "2-s2.0-85061267681",
    "title": "Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: A phase III, double-blind, randomized study",
    "cover-date": "2019-02-07",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pediatrics, Perinatology and Child Health",
            "@code": "2735",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Human serum albumin",
        "Non-inferiority",
        "Safety",
        "Varicella vaccine"
    ],
    "authors": [
        "Saul N. Faust",
        "Maguelone Le Roy",
        "Chitsanu Pancharoen",
        "Miguel Angel Rodriguez Weber",
        "Katrina Cathie",
        "Ulrich Behre",
        "Jolanta Bernatoniene",
        "Matthew D. Snape",
        "Klaus Helm",
        "Carlos Eduardo Medina Pech",
        "Ouzama Henry",
        "Carmen Baccarini",
        "Michael Povey",
        "Paul Gillard"
    ],
    "citedby-count": 4,
    "ref-count": 14,
    "ref-list": [
        "WHO position paper, June 2014",
        "Varicella vaccination - The global experience",
        "Sixteen years of global experience with the first refrigerator-stable varicella vaccine (Varilrix)",
        "Review of the Varilrix varicella vaccine",
        "Varicella vaccine without human serum albumin versus licensed varicella vaccine in children during the second year of life: A randomized, double-blind, non-inferiority trial",
        "The Brighton collaboration-enhancing vaccine safety",
        "Subcommittee on Febrile Seizures American Academy of Pediatrics. Febrile seizures: Clinical practice guideline for the long-term management of the child with simple febrile seizures",
        "Fever in children: Pearls and pitfalls",
        "Varicella vaccination-a critical review of the evidence",
        "Evaluation of a live attenuated varicella vaccine in 15- to 18-month-old healthy children",
        "Reactogenicity to a live attenuated varicella vaccine in Canadian children"
    ],
    "affiliation": [
        {
            "affiliation-city": "Philadelphia",
            "@id": "60097308",
            "affilname": "GlaxoSmithKline, USA",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60097308",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bristol",
            "@id": "60170515",
            "affilname": "University Hospitals Bristol and Weston NHS Foundation Trust",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60170515",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Wavre",
            "@id": "60111446",
            "affilname": "GlaxoSmithKline Pharmaceuticals SA/NV",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60111446",
            "affiliation-country": "Belgium"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Southampton",
            "@id": "60025225",
            "affilname": "University of Southampton",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025225",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Mexico",
            "@id": "60004914",
            "affilname": "Instituto Nacional de Pediatr\u00eda",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004914",
            "affiliation-country": "Mexico"
        },
        {
            "affiliation-city": "Oxford",
            "@id": "60002634",
            "affilname": "University of Oxford Medical Sciences Division",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002634",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Merida",
            "@id": "122142458",
            "affilname": "Medical Care and Research SA de CV",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122142458",
            "affiliation-country": "Mexico"
        },
        {
            "affiliation-city": "Detmold",
            "@id": "116502249",
            "affilname": "Private Practice",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/116502249",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Kehl",
            "@id": "101695716",
            "affilname": "Private Practice",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101695716",
            "affiliation-country": "Germany"
        }
    ],
    "funding": [
        "GlaxoSmithKline Biologicals SA"
    ]
}